Recall archive / FDA company announcement

Vitruvias Therapeutics: Thyroid Tablets, USP 30 mg — FDA announcement Aug 24, 2026

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Aug 24, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Thyroid Tablets, USP 30 mg
Reason: Potential for the Product to be Superpotent
Classification: Not supplied
Recalling firm: Vitruvias Therapeutics, Inc
Quantity: Not supplied
Agency-reported status: Company recall announcement
Source record identifier: 19092c9309b8774e

Open the official record

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	AUBURN, Ala. (August 21, 2026) – Vitruvias Therapeutics Inc. is voluntarily recalling one lot (Lot. No. 504950) of Thyroid Tablets, USP 30 mg to the consumer level. The product is being recalled because testing confirmed the potential for the product to be superpotent.; To best identify the product, the NDC, Product Description, Lot Number, and Expiration Date are listed below.; Lot 504950 was distributed nationwide in the USA to Vitruvias Therapeutics' direct accounts from Jan. 31, 2025 to Sept. 30, 2025.; Vitruvias Therapeutics is proactively notifying its wholesalers by email and phone to discontinue distribution of the product being recalled and is arranging for destruction of all recalled product. Patients who are currently taking Thyroid, USP from Lot 504950, which is being recalled, should not discontinue use without contacting their healthcare provider for further guidance and/or a replacement prescription.; Product \| NDC \| Lot \| Exp Date \| Units Released \| Units Sold \| First Distribution Date \| Last Distribution Date; Thyroid Tablets, USP 30 mg \| 69680- 166-00 \| 504950 \| 9/30/2026 \| 3,655 \| 1955 \| 1/31/2025 \| 9/30/2025

Label field

Details supplied by the agency

Lot, code or applicability

AUBURN, Ala. (August 21, 2026) – Vitruvias Therapeutics Inc. is voluntarily recalling one lot (Lot. No. 504950) of Thyroid Tablets, USP 30 mg to the consumer level. The product is being recalled because testing confirmed the potential for the product to be superpotent.; To best identify the product, the NDC, Product Description, Lot Number, and Expiration Date are listed below.; Lot 504950 was distributed nationwide in the USA to Vitruvias Therapeutics' direct accounts from Jan. 31, 2025 to Sept. 30, 2025.; Vitruvias Therapeutics is proactively notifying its wholesalers by email and phone to discontinue distribution of the product being recalled and is arranging for destruction of all recalled product. Patients who are currently taking Thyroid, USP from Lot 504950, which is being recalled, should not discontinue use without contacting their healthcare provider for further guidance and/or a replacement prescription.; Product | NDC | Lot | Exp Date | Units Released | Units Sold | First Distribution Date | Last Distribution Date; Thyroid Tablets, USP 30 mg | 69680- 166-00 | 504950 | 9/30/2026 | 3,655 | 1955 | 1/31/2025 | 9/30/2025

Match all identifying details in the current notice. A brand name alone is not enough.

Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

FDA company announcement, table 1
Product	NDC	Lot	Exp Date	Units Released	Units Sold	First Distribution Date	Last Distribution Date
Thyroid Tablets, USP 30 mg	69680- 166-00	504950	9/30/2026	3,655	1955	1/31/2025	9/30/2025

Announcement retrieved Oct 1, 2026. Official announcement.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date: Aug 24, 2026
Company announcement date: Aug 21, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.